Alpha Cognition (ACOG) Cost of Revenue (2025)

Alpha Cognition's (ACOG) quarterly Cost of Revenue came in at $179334.0 in Q4 2025, up 10.17% quarter-over-quarter from $162777.0 in Q3 2025.

Alpha Cognition (ACOG) Cost of Revenue (2025) Analysis & Trends

Alpha Cognition's Cost of Revenue history runs 1 years deep, the most recent figure standing at $179334.0 for Q4 2025.

On a quarterly basis, Cost of Revenue changed N/A year-over-year to $179334.0 in Q4 2025; TTM through Dec 2025 was $809631.0, a N/A change from a year earlier, with the FY2025 full-year figure at $474006.0, changed N/A from the prior year.
Cost of Revenue improved to $179334.0 in Q4 2025 per ACOG's latest filing, from $162777.0 in the prior quarter.
Across five years, Cost of Revenue topped out at $440979.0 in Q2 2025 and bottomed at $26541.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cost of Rev (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn	167.22 Mn
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn	392.80 Mn
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn	296.00 Mn
7	Belite Bio	62.72 Bn	62.72 Bn	-	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn	145.00 Mn
9	Revolution Medicines	37.35 Bn	37.35 Bn	-	-
10	Alpha Cognition	146.84 Mn	80.73 Mn	2.61 Mn	179,334.00

Download Data